BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 27050297)

  • 1. Chronic cerebral hypoperfusion enhances Tau hyperphosphorylation and reduces autophagy in Alzheimer's disease mice.
    Qiu L; Ng G; Tan EK; Liao P; Kandiah N; Zeng L
    Sci Rep; 2016 Apr; 6():23964. PubMed ID: 27050297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long term changes in phospho-APP and tau aggregation in the 3xTg-AD mice following cerebral ischemia.
    Koike MA; Garcia FG; Kitazawa M; Green KN; Laferla FM
    Neurosci Lett; 2011 May; 495(1):55-9. PubMed ID: 21419194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NDP52 associates with phosphorylated tau in brains of an Alzheimer disease mouse model.
    Kim S; Lee D; Song JC; Cho SJ; Yun SM; Koh YH; Song J; Johnson GV; Jo C
    Biochem Biophys Res Commun; 2014 Nov; 454(1):196-201. PubMed ID: 25450380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous administration of mesenchymal stem cells reduces Tau phosphorylation and inflammation in the 3xTg-AD mouse model of Alzheimer's disease.
    Neves AF; Camargo C; Premer C; Hare JM; Baumel BS; Pinto M
    Exp Neurol; 2021 Jul; 341():113706. PubMed ID: 33757765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selenomethionine Mitigates Cognitive Decline by Targeting Both Tau Hyperphosphorylation and Autophagic Clearance in an Alzheimer's Disease Mouse Model.
    Zhang ZH; Wu QY; Zheng R; Chen C; Chen Y; Liu Q; Hoffmann PR; Ni JZ; Song GL
    J Neurosci; 2017 Mar; 37(9):2449-2462. PubMed ID: 28137967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acyl-coenzyme A:cholesterol acyltransferase 1 blockage enhances autophagy in the neurons of triple transgenic Alzheimer's disease mouse and reduces human P301L-tau content at the presymptomatic stage.
    Shibuya Y; Niu Z; Bryleva EY; Harris BT; Murphy SR; Kheirollah A; Bowen ZD; Chang CCY; Chang TY
    Neurobiol Aging; 2015 Jul; 36(7):2248-2259. PubMed ID: 25930235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transgenic autoinhibition of p21-activated kinase exacerbates synaptic impairments and fronto-dependent behavioral deficits in an animal model of Alzheimer's disease.
    Bories C; Arsenault D; Lemire M; Tremblay C; De Koninck Y; Calon F
    Aging (Albany NY); 2017 May; 9(5):1386-1403. PubMed ID: 28522792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
    Clausen A; Xu X; Bi X; Baudry M
    J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Active full-length DNA Aβ
    Rosenberg RN; Fu M; Lambracht-Washington D
    Alzheimers Res Ther; 2018 Nov; 10(1):115. PubMed ID: 30454039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a 3xTg-AD mouse model of Alzheimer's disease with the senescence accelerated mouse prone 8 (SAMP8) background.
    Virgili J; Lebbadi M; Tremblay C; St-Amour I; Pierrisnard C; Faucher-Genest A; Emond V; Julien C; Calon F
    Synapse; 2018 Apr; 72(4):. PubMed ID: 29341269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Micro-RNA-137 Inhibits Tau Hyperphosphorylation in Alzheimer's Disease and Targets the CACNA1C Gene in Transgenic Mice and Human Neuroblastoma SH-SY5Y Cells.
    Jiang Y; Xu B; Chen J; Sui Y; Ren L; Li J; Zhang H; Guo L; Sun X
    Med Sci Monit; 2018 Aug; 24():5635-5644. PubMed ID: 30102687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunolesion-induced loss of cholinergic projection neurones promotes β-amyloidosis and tau hyperphosphorylation in the hippocampus of triple-transgenic mice.
    Härtig W; Saul A; Kacza J; Grosche J; Goldhammer S; Michalski D; Wirths O
    Neuropathol Appl Neurobiol; 2014 Feb; 40(2):106-20. PubMed ID: 23566195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Twendee X Ameliorates Phosphorylated Tau, α-Synuclein and Neurovascular Dysfunction in Alzheimer's Disease Transgenic Mice With Chronic Cerebral Hypoperfusion.
    Liu X; Yamashita T; Shang J; Shi X; Morihara R; Huang Y; Sato K; Takemoto M; Hishikawa N; Ohta Y; Abe K
    J Stroke Cerebrovasc Dis; 2019 Oct; 28(10):104310. PubMed ID: 31383622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic low dose of AM404 ameliorates the cognitive impairment and pathological features in hyperglycemic 3xTg-AD mice.
    Huang HJ; Chen SL; Huang HY; Sun YC; Lee GC; Lee-Chen GJ; Hsieh-Li HM; Su MT
    Psychopharmacology (Berl); 2019 Feb; 236(2):763-773. PubMed ID: 30426182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toluidine blue O modifies hippocampal amyloid pathology in a transgenic mouse model of Alzheimer's disease.
    Yuksel M; Biberoglu K; Onder S; Akbulut KG; Tacal O
    Biochimie; 2018 Mar; 146():105-112. PubMed ID: 29248542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of Cdk5/p25 and tau phosphorylation following chronic brain hypoperfusion in rats involves microRNA-195 down-regulation.
    Sun LH; Ban T; Liu CD; Chen QX; Wang X; Yan ML; Hu XL; Su XL; Bao YN; Sun LL; Zhao LJ; Pei SC; Jiang XM; Zong DK; Ai J
    J Neurochem; 2015 Sep; 134(6):1139-51. PubMed ID: 26118667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective neurodegeneration of the hippocampus caused by chronic cerebral hypoperfusion: F-18 FDG PET study in rats.
    Lee JI; Lim JS; Hong JH; Kim S; Lee SW; Ji HD; Won KS; Song BI; Kim HW
    PLoS One; 2022; 17(2):e0262224. PubMed ID: 35143502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rifampicin is a candidate preventive medicine against amyloid-β and tau oligomers.
    Umeda T; Ono K; Sakai A; Yamashita M; Mizuguchi M; Klein WL; Yamada M; Mori H; Tomiyama T
    Brain; 2016 May; 139(Pt 5):1568-86. PubMed ID: 27020329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oligemic hypoperfusion differentially affects tau and amyloid-{beta}.
    Koike MA; Green KN; Blurton-Jones M; Laferla FM
    Am J Pathol; 2010 Jul; 177(1):300-10. PubMed ID: 20472896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic cerebral hypoperfusion upregulates leptin receptor expression in astrocytes and tau phosphorylation in tau transgenic mice.
    Shimada T; Shindo A; Matsuyama H; Yata K; Niwa A; Sasaki R; Ayaki T; Maki T; Wakita H; Tomimoto H
    Neurosci Lett; 2019 Jun; 704():133-140. PubMed ID: 30954605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.